Our portfolio

Cellagenics

Cellagenics

Developing STEP® technology, Cellagenics scales up therapeutic antibody production in mammalian cell lines. Their collaboration with Batavia Biosciences aims to enhance biopharmaceutical manufacturing.

Industry: Therapeutics

Want to get in contact about Cellagenics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Amplifying treatment of chronic autoimmune diseases.
Enhancing microscopes with low-power super-resolution imaging solutions.
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Amplifying treatment of chronic autoimmune diseases.
Enhancing microscopes with low-power super-resolution imaging solutions.
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer